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Two cases of bilateral radiation pneumonitis associated with unilateral thoracic irradiation against lung cancer are
described. Both patients died of respiratory failure and autopsy was performed. Histologically, bilateral diuse
alveolar damage was demonstrated in both cases, associated with marked organization of hyaline membrane in one
case (case 1). In addition, numerous hyperplastic type II pneumocytes which strongly expressed cytokeratins 8, 18
and 19 were observed. In both patients’ sera, antibodies against cytokeratin 8, 18 and 19 were demonstrated by a
Western immunoblot. The possible association between autoantibodies to cytokeratins and diuse alveolar damage
observed in patients with bilateral radiation pneumonitis are discussed.
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The pathogenesis of radiation pneumonitis has been poorly
explained, but involves the assumption that irradiation
leads to chromosomal damage and cell death, with
replacement of cells by ‘scarring’ and ‘fibrosis’, or the
accompanying vascular damage (1,2).
There are approximately 40 dierent cell types in the lung
(3); among them, the type II pneumocytes, which are the
principal source of surfactant and have the fastest turnover
rate. Since radiation injury is secondary to mitotic cell
death, the type II pneumocyte is most closely linked to the
mechanistic theories underlying radiation pneumonitis.
Pathophysiologically, it has been reported that radiation
pneumonitis is an alveolitis resulting from damage to the
alveolar type II pneumocytes that maintain alveolar
patency (1).
Clinically, it has been reported that radiation pneumo-
nitis is sometimes observed outside the irradiated area
(2,4,5). However, the pathogenesis of unilateral as well as
bilateral radiation pneumonitis has not been clarified (2).
In the present study, we report two cases of bilateral
radiation pneumonitis after unilateral thoracic irradiationPaper received 1 December 1999 and accepted in revised form 28
March 2000.
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0954-6111/00/090875+06 $35?00/0against primary lung cancer, and hypothesize that anti-
human epithelial cell antibodies play a role in the
pathogenesis of bilateral radiation pneumonitis.
Materials and methods
SUBJECTS
Case 1
A 67-year-old man was admitted to the Kagawa Medical
University Hospital because of abnormal shadow on chest
X-ray. He had a medical history of chronic active hepatitis
caused by hepatitis virus C and had smoked for 40 pack-
years. Chest computed tomography (CT) demonstrated a
coin lesion in the right lower lobe and mediastinal lymph
node swelling. He was diagnosed with small cell lung cancer
by the chest CT-guided biopsy. He was treated with four
courses of combination chemotherapy and radiation
therapy to the primary lesion as well as the mediastinal
lymph node. He experienced localized radiation pneumo-
nitis which was controlled with oral prednisolone and then
discharged. Two weeks later, there was a rapid sympto-
matic progression of his dyspnoea and he was subsequently
admitted to the hospital. Chest CT scan revealed a bilateral
interstitial shadow (Fig. 1). On physical examination, he
had a high fever with a respiratory rate of 40 min71, blood
pressure of 90/50mmHg, and a regular pulse rate of
140min71. The chest was symmetric, and bibasilar coarse# 2000 HARCOURT PUBLISHERS LTD
FIG. 1. Chest CT finding of case 1 on admission (16 April
1999). Bilateral interstitial consolidations are
demonstrated.
FIG. 2. Chest X-ray findings of case 2 (28 December 1998).
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showed a PO2 of 39?3 mmHg, PCO2 of 35?5 mmHg, AaDO2
of 66 mmHg, and pH 7?45. Chest X-ray and CT (Fig. 1)
revealed a diuse bilateral interstitial infiltrate in both
lungs. He was diagnosed with radiation pneumonitis and
intravenous methylprednisolone and respiratory care by
ventilator was started. However, the interstitial shadow had
progressed and he died 2 weeks later. Autopsy was
performed. In this case, cytokeratin 19 fragment (6) in the
serum was monitored. Serum cytokeratin 19 fragments
were significantly increased after the onset of bilateral
radiation pneumonitis (from 2?5 ngml71 before radiation
pneumonitis to 36?6 ngml71 after radiation pneumonitis,
compared to a normal value of 2?0 ngml71).
Case 2
A 74-year-old man was admitted to the Kochi Medical
School Hospital because of an abnormal shadow on chest
X-ray. He had medical history of chronic active hepatitis
caused by hepatitis virus C and had smoked for 50 pack-
years. Chest CT demonstrated a mass lesion in the left
lower lobe. He was diagnosed with adenocarcinoma of the
lung by a chest CT-guided biopsy. He was treated with
radiation therapy (total 60 Gy). He experienced localized
radiation pneumonitis and was treated with oral predniso-
lone. However, his pneumonitis progressed. On physical
examination, he was febrile with a respiratory rate of
30min71, blood pressure of 158/80 mm Hg, and a regular
pulse rate of 78min71. The chest was symmetric, and
bibasilar coarse crackles were auscultated. Arterial blood
gas analysis showed a PO2 of 78 mmHg, PCO2 of 39 mmHg,
AaDO2 of 32 mmHg, and pH 7?45. Chest X-ray and CT
(Fig. 2) revealed a diuse bilateral interstitial infiltrate in
both lungs. He was diagnosed with bilateral radiation
pneumonitis and intravenous methylprednisolone and
respiratory care by ventilator was started. However, the
interstitial shadow progressed and he died 2 weeks later.
Autopsy was performed.WESTERN IMMUNOBLOT
To evaluate the existence of antibodies against lung
proteins, Western immunoblot analysis was performed.
SDS-polyacrylamide gel and electrophoresis was performed
according to the Laemmli’s method (7) with a slight
modification. Cell lysates of several lung cancer cell lines
were then applied to a 10/20 % SDS polyacrylamide gel and
electrophoresed (60mA, 120min). Then, proteins were
electrophoretically transferred onto a nitrocellulose mem-
brane by the method of Towbin et al. (8). Proteins were
detected by immunoblotting, using the patient’s serum (1:50
dilution), peroxidase conjugated goat anti-human IgG
antibody (Sigma ImmunoChemicals, lot 094H-4810, St
Louis, MO, U.S.A.), and stained with 4CN PLUS for
chromogenic detection of horse radish peroxidase (NEMTM
Life Science Products, Boston, MA, U.S.A.). Adenocarci-
noma cell lines (A549, PC3, PC9, RERF-LC-OK, and LC2/
AD), as well as squamous cell carcinoma cell lines (EBC-1,
VMRC-LCD and LC1/SQ), were used to detect autoanti-
bodies. Recombinant cytokeratin 8 (PROGEN BIOTECH-
NIK GMBH, Heidelberg, Germany) and cytokeratin 19
(PROGEN BIOTECHNIK GMBH, Heidelberg, Germany)
were also used as antigens. Bovine cytokeratin 18 (PRO-
GEN BIOTECHNIK GMBH, Heidelberg, Germany) was
also used in a dierent experiment.
FIG. 3. Western immunoblot analysis using the patient’s
sera against lysates of several lung cancer cell lines. (A)
case 1, (B) case 2. Lane 1: recombinant human cytokeratin
8; lane 2: A549 cell line (adenocarcinoma); lane 3: PC3
(adenocarcinoma); lane 4: PC9 (adenocarcinoma); lane 5:
RERF-LC-OK (adenocarcinoma); lane 6: LC2/AD
(adenocarcinoma); lane 7: EBC-1 (squamous cell
carcinoma); lane 8: VMRC-LCD (squamous cell
carcinoma); lane 9: LC1/SQ (squamous cell carcinoma);
lane 10: recombinant human cytokeratin 19. The bands
correspond to cytokeratin 8 with increased amounts of
carbohydrates (*), cytokeratin 8 (**), cytokeratin 18 (***)
and cytokeratin 19 (****). Numbers on the left represent
molecular weight markers.
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AUTOPSIED LUNG
In case 1, each lobe of the lung was found to have
organizing diuse alveolar damage (DAD). The collapse of
alveoli with fibrosis was more severe in the subpleural
region, than in the deeper part, and irregular small
multicystic changes associated with organized hyaline
membrane were widely found. Proliferating type II alveolar
cells with atypism were found in the intervening areas of
small cystic change. In case 1, organizing DAD (acute
interstitial pneumonia) was found in both lungs. A few
remaining cancer cells were detected in the right lower lobe.
In case 2, general figures were similar to case 1, but no
organization of the hyaline membrane was found. No
remaining cancer cells were detected. General changes were
much more intensive in the left lung, but in the right, DAD
pattern was also found. Case 2 was diagnosed as bilateral
radiation pneumonitis with DAD pattern.
To evaluate the expression of several cytokeratins in
autopsied lungs, immunohistochemical staining by anti-
human monoclonal antibodies against several cytokeratins
was performed. Lung tissues were immunohistochemically
stained, employing the avidin–biotin peroxidase complex
method (Dako LSAB kit-peroxidase, DAKO Corp.,
Kyoto, Japan) using mouse monoclonal antibodies to
cytokeratins. Monoclonal antibodies used were as follows;
35bH11 (MA902) which detects cytokeratin 8 (Enzo
Diagnostics, Inc., New York, NY, U.S.A., 1:5000 dilution),
anti-human cytokeratins 18 and 19 (ScyTek Lab., Logan,
UT, each 1:30 dilution), and a-smooth muscle actin
(DAKO, Glostrup, Denmark, 1:200 dilution). In order to
retrieve and increase the immunoreactivities, preincubation
with 0.1% pronase at 378C for 20min was performed for
cytokeratins 18 and MA902. For cytokeratin 19, autoclave
treatment at 132oC for 12min was also carried out.
A COMPUTER SEARCH FOR THE
CLEAVAGE SITE OF CASPASE IN
CYTOKERATIN 8, CYTOKERATIN 18 AND
CYTOKERATIN 19
Since we hypothesized that apoptosis of type II pneumo-
cytes caused by radiation played a significant role in the
formation of anti-cytokeratin antibodies, we evaluated the
existence of cleavage sites of caspase in cytokeratin 8,
cytokeratin 18 and cytokeratin 19.
Results
Western immunoblot analysis showed that several anti-
bodies against human lung cancer cell lines were demon-
strated in both patients’ sera (Fig. 3). Several anti-epithelial
cell antibodies were demonstrated by a Western immuno-
blot analysis. Among them, anti-cytokeratin 8 and anti-
cytokeratin 19 antibodies were confirmed by the reaction
with recombinant human cytokeratin 8 as well as cytoker-
atin 19 (Fig. 3). Anti-cytokeratin 18 antibody wasconfirmed by using bovine cytokeratin 18 (data not shown).
Sera from normal volunteers demonstrated no positive
antibodies against human lung cancer cell lines (data not
shown).
Immunohistochemical staining demonstrated that regen-
erated alveolar type II cells were strongly stained by anti-
human cytokeratin 8 [Fig. 4(A)], cytokeratin 18 [Fig. 4(B)]
and cytokeratin 19 [Fig. 4(C)]. Hyaline membranes in case 2
were positive only for cytokeratin 19, but not cytokeratin 8
and 18 [Fig. 4(C)]. Anti-a-smooth muscle actin antibody
was negative to hyaline membranes. In case 1, hyaline
membranes were organized to be positive for anti-a-smooth
muscle actin, but not cytokeratin 19, and alveolar type II
cells in collapsed alveoli were cytokeratin-positive, prolif-
erating in intervening areas of cystic spaces covered by
organized hyaline membranes (data not shown).
After a computer search, we found the cleavage site of
caspase in cytokeratin 8, cytokeratin 18 and cytokeratin 19
(Fig. 5).
Discussion
In this report, we describe two cases of bilateral radiation
pneumonitis complicated by unilateral radiation therapy
for lung cancer. In these patients’ sera, we also demon-
strated antibodies to lung cancer cell lines, including anti-
cytokeratin 8, anti-cytokeratin 18 and anti-cytokeratin 19.
There have been sporadic reports of bilateral radiation
pneumonitis (2,4,5) in which the pathogenesis has largely
been unexplained. There have been reports of diuse
gallium scan uptake in radiation pneumonitis (9,10). It
FIG. 4. Immunohistochemical staining of autopsied lung
by anti-cytokeratin 8 (A), anti-cytokeratin 18 (B) and
anti-cytokeratin 19 (C) antibodies in case 2.
Immunohistochemical staining demonstrate that
regenerated alveolar type II cells are strongly stained by
anti-human cytokeratin 8 (A, right upper lobe, 6110),
cytokeratin 18 (B, left upper lobe,6110), and cytokeratin
19 (C, left upper lobe, 6220). These reactions are
observed in bilateral lungs of both patients. Note positive
staining of hyaline membrane (arrow) with anti-
cytokeratin 19 antibody (C).
FIG. 5. A computer search for the cleavage site of caspase
in cytokeratin 8, cytokeratin 18 and cytokeratin 19. The
caspase cleavage sites are demonstrated in cytokeratin 8,
cytokeratin 18 and cytokeratin 19.
878 J. FUJITA ET AL.has also been reported that there are no statistically
significant dierences between bronchoalveolar lavage
findings in irradiated and non-irradiated sides of the chest,
in either pre- or post-treatment, and with or without clinical
pneumonitis (11,12). More recently, however, Halme et al.
have reported that a high surfactant protein-A/phospholi-
pid ratio and a high level of surfactant protein-A in
bronchoalveolar lavage fluid (BALF) before radiation
therapy, is associated with a high degree of radiation-
induced lung injury measured by lung function tests and
computed tomography (13).
The accepted explanation for development of radiation
pneumonitis has largely centered around the process of
cellular damage, particularly the type II pneumocytes, and
the resultant alteration in production and release of
pulmonary surfactant that is needed to prevent atelectasis
of the lung (2). However, the findings of bilateral
lymphocytosis and diuse changes on gallium lung scan is
undoubtedly a dierent process from that which has been
described in localized radiation pneumonitis, which is
characterized by the inflammatory consequences of direct
irradiation injury to pulmonary tissue (2). In bilateral
radiation pneumonitis, it has been speculated that following
lung irradiation, there is damage to non-irradiated lung
tissue that is caused by an immune response to the damaged
lung tissue. In individuals who are more susceptible because
of other factors (e.g., genetic or environmental), this
response is more marked and leads to a clinical picture of
bilateral radiation pneumonitis (2). In addition, the
existence of anti-cytokeratin antibody may provide some
pretreatment indication of patients at particular risk of
developing pneumonitis.
In our present study, we demonstrate anti-cytokeratin
antibodies in two patients with bilateral radiation pneu-
monitis. Therefore, the significance of anti-cytokeratin 8, 18
and 19 autoantibodies in these patients in the pathogenesis
of bilateral radiation pneumonitis should be discussed.
Iyonaga et al. have revealed that hyperplastic type II cells
strongly express cytokeratins 7, 8 and 19 (14). In addition,
some studies have shown that antibodies can penetrate cells
in vivo (15). Therefore, antibodies that bind to cytokeratin
BILATERAL RADIATION PNEUMONITIS 8798, 18 and 19 may be pathologically significant since defects
in intermediate filaments may be capable of disrupting the
cell function of type II cells. In addition, cytokeratin 8, 18
and 19 may be released from type II pneumocytes, which
were activated to express these cytokeratins, following cell
injury caused by radiation. The resulting antibody–antigen
interaction with immune complex formation could have a
significant role in the perpetuation of the disease process,
either by direct injury of epithelial cells or via local
macrophage activation as they are cleared by phagocytosis
(16).
The mechanism of formation of these antibodies should
also be discussed. The cytokeratin 8 and 18 filaments have
been shown to undergo dramatic reorganization during
apoptosis, while their phosphorylation status does not seem
to exert any eect on their susceptibility to caspases (17,18).
In radiation induced lung injury, it has been suggested that
apoptosis of type II pneumocytes plays an important role
(17). Apoptosis is characterized by ultrastructural changes
that include actin cytoskeletal disruption, membrane
blebbing, decreases in adhesion and intercellular contacts,
chromatin condensation, nuclear fragmentation and packa-
ging of nuclear fragments into membrane enclosed apopto-
tic bodies (19). Among the many biochemical changes,
limited proteolysis of specific cellular proteins by the
caspase family of cysteine proteases appear to be important
(20,21). It has been reported that cytokeratin 8 and
cytokeratin 19 contain the caspase cleavage site (17). In
addition, we also demonstrate the caspase cleavage site in
cytokeratin 18. Therefore, it is possible that fragments of
cytokeratin 8, 18 and 19 were released to the blood vessels
after radiation injury, and these fragments may have
played a role in the formation of circulating autoantibodies.
To prove this, antigenic epitopes of these cytokeratins to
which patients’ sera reacted should be clarified in future
studies.
We could not rule out the possibility that the existence of
cytokeratin 8, 18 and 19 autoantibodies were a non-specific
consequence of lung injury. Therefore, the significance of
anti-cytokeratin 8, 18 and 19 antibodies in the pathogenesis
of bilateral radiation pneumonitis should be evaluated in
future studies.
In summary, we present two cases of bilateral radiation
pneumonitis after unilateral thoracic irradiation. We also
suggest that anti-epithelial cell antibodies including anti-
cytokeratin 8, 18, and 19 antibodies may have played a role
in the pathogenesis of bilateral radiation pneumonitis.
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